Latest Conference Coverage


Bruce Cree, MD, PhD, MAS, professor of clinical neurology at University of California San Francisco (UCSF) Weill Institute for Neurosciences and clinical research director, UCSF MS Center

Phase 3 DAYBREAK Trial Highlights Long-Term Efficacy of Ozanimod for Relapsing Multiple Sclerosis

February 29th 2024

Long-term data from the phase 3 DAYBREAK trial affirmed sustained efficacy of ozanimod for relapsing forms of multiple sclerosis, with a high amount of patients who were relapse-free at 6 years.


Ashkan Shoamanesh, MD

Secondary Analyses of ANNEXA-I Trial Assessing Andexanet Alfa in Intracranial Hemorrhage: Ashkan Shoamanesh, MD

February 28th 2024

The associate professor of neurology at McMaster University talked about findings from secondary analyses on the phase 4 ANNEXA-I trial assessing andexanet alfa in patients with acute intracerebral hemorrhage. [WATCH TIME: 10 minutes]


Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

February 26th 2024

The professor of emergency medicine at Washington University in St. Louis and associate professor of neurosurgery at UTHealth Houston talked about results from the phase 3 MOST trial assessing argatroban and eptifibatide in acute ischemic stroke. [WATCH TIME: 3 minutes]


David Z. Rose, MD

Cost-Effective Detection of Poststroke Atrial Fibrillation Identified in STROKE-AF Trial: David Z. Rose, MD

February 25th 2024

The professor of neurology at University of South Florida talked about the cost-effectiveness of insertable cardiac monitors to detect new atrial fibrillation in patients with large-artery or small-vessel disease stroke. [WATCH TIME: 4 minutes]


Future Role of Neurofilament Light in ALS Drug Development, Clinical Trials: Rita Sattler, PhD, MSc

Future Role of Neurofilament Light in ALS Drug Development, Clinical Trials: Rita Sattler, PhD, MSc

February 23rd 2024

The professor in the Department of Translational Neuroscience at Barrow Neurological Institute provided perspective on the approval of tofersen (Qalsody; Biogen) for patients with ALS and the ways neurofilament light will be used going forward. [WATCH TIME: 3 minutes]


Shadi Yaghi, MD, associate professor of neurology at Brown University

Antiplatelets Versus Anticoagulation For the Treatment of Cervical Artery Dissection: Shadi Yaghi, MD

February 22nd 2024

The associate professor of neurology at Brown University talked about findings from an observational study investigating treatment options antiplatelets and anticoagulation for cervical artery dissection. [WATCH TIME: 8 minutes]


Lessons Learned From Cleveland Clinic’s Mobile Stroke Unit: Blake Buletko, MD

Lessons Learned From Cleveland Clinic’s Mobile Stroke Unit: Blake Buletko, MD

February 22nd 2024

The vascular neurologist and director of the residency program at Cleveland Clinic provided perspective on the biggest learning experiences over the past decade for Cleveland Clinic’s mobile stroke unit. [WATCH TIME: 4 minutes]


Ava L. Liberman, MD, medical director of the Stroke Center at Weill Cornell Medicine

Assessing In-Hospital Stroke Risk in Pregnant Patients Using Assisted Reproductive Technologies: Ava L. Liberman, MD

February 21st 2024

The medical director of the Stroke Center at Weill Cornell Medicine talked about results from a recent study on the risk of stroke in patients on assisted reproductive technologies during delivery hospitalization. [WATCH TIME: 4 minutes]


NeuroVoices: Rita Sattler, MD, MSc, on 2024 MDA Conference and Advances in ALS Research

NeuroVoices: Rita Sattler, MD, MSc, on 2024 MDA Conference and Advances in ALS Research

February 21st 2024

The professor in the Department of Translational Neuroscience at Barrow Neurological Institute discussed several topics related to ALS research and the emerging biomarkers in recent years ahead of the 2024 MDA Clinical and Scientific Conference.


Potential of Mobile Stroke Units to Acutely Treat Intracerebral Hemorrhage: Blake Buletko, MD

Potential of Mobile Stroke Units to Acutely Treat Intracerebral Hemorrhage: Blake Buletko, MD

February 20th 2024

The vascular neurologist and director of the residency program at Cleveland Clinic provided perspective on a recently conducted study showing the benefits of timely treatment through mobile stroke units for patients with acute intracerebral hemorrhage. [WATCH TIME: 6 minutes]


The Emergence of Novel Biomarkers and Model Systems for ALS: Rita Sattler, MD, MSc

The Emergence of Novel Biomarkers and Model Systems for ALS: Rita Sattler, MD, MSc

February 19th 2024

The professor in the Department of Translational Neuroscience at Barrow Neurological Institute provided comments on her session track at the upcoming 2024 MDA conference and some of the recent advancements in ALS research. [WATCH TIME: 4 minutes]


Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

February 18th 2024

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]


Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

Head-of-Bed Positioning Impact on Patients' Recovery Following Thrombectomy: Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

February 16th 2024

The professor of nursing and neurology at the University of Tennessee Health Science Center talked about findings from a study investigating head-of-bed position in patients undergoing thrombectomy which was presented at ISC 2024. [WATCH TIME: 6 minutes]


Understanding Patient Subgroups Who Benefit From Tenecteplase After 4.5 Hours: Gregory W. Albers, MD

Understanding Patient Subgroups Who Benefit From Tenecteplase After 4.5 Hours: Gregory W. Albers, MD

February 16th 2024

The professor of neurology and director of the Stanford Stroke Center provided commentary on clinical implications of findings from the TIMELESS trial assessing tenecteplase initiated in the late window after stroke onset. [WATCH TIME: 4 minutes]


Annabel Sorby-Adams, PhD

Using a Portable Low Field MRI for Timely Diagnoses of Stroke: Annabel Sorby-Adams, PhD

February 15th 2024

The postdoctoral research fellow in neurology at Harvard Medical School talked about the potential of a portable low field MRI device to provide timely and cost-effective diagnoses for stroke. [WATCH TIME: 4 minutes]


Next Steps Following EMBOLISE Trial and Addressing Unmet Needs for Subdural Hematomas: Jason M. Davies, MD, PhD

Next Steps Following EMBOLISE Trial and Addressing Unmet Needs for Subdural Hematomas: Jason M. Davies, MD, PhD

February 15th 2024

The assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo discussed the questions that still remain following the EMBOLISE trial and the use of embolization in the treatment of subacute and subdural hematoma. [WATCH TIME: 5 minutes]


Ava L. Liberman, MD

Assisted Reproductive Technologies Increase Risk of In-Hospital Stroke in Pregnant Women

February 14th 2024

In a recent study presented at ISC 2024, results revealed that patients who used assisted reproductive technologies therapy during hospitalization for delivery had a higher risk of stroke than those who did not use such therapies.


Shadi Yaghi, MD

Anticoagulation Reduces Risk of Stroke in Cervical Artery Dissection, With Effects Based on Timing

February 13th 2024

A recent study showed anticoagulation reduced ischemic stroke risk in patients with cervical artery dissection; however, cautioned is warned about the importance of transitioning to antiplatelet therapy at a certain point.


Anti-Inflammatory Agent RNS60 Demonstrates Robust Impact on Poststroke Disability in Phase 2 RESCUE Study

Anti-Inflammatory Agent RNS60 Demonstrates Robust Impact on Poststroke Disability in Phase 2 RESCUE Study

February 13th 2024

Topline results from the RESCUE trial indicate that RNS60, an anti-inflammatory agent, demonstrates safety and potential efficacy in acute ischemic stroke.


Insights on the EMBOLISE Trial and Advancing Treatment for Subdural Hematoma: Jason M. Davies, MD, PhD

Insights on the EMBOLISE Trial and Advancing Treatment for Subdural Hematoma: Jason M. Davies, MD, PhD

February 12th 2024

The assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo provided commentary on the significant findings from the EMBOLISE trial presented at the 2024 International Stroke Conference. [WATCH TIME: 4 minutes]


AI-Based Support System Provides Significant Benefits to Stroke Care

AI-Based Support System Provides Significant Benefits to Stroke Care

February 12th 2024

Using a cohort of more than 20,000 patients with ischemic stroke, those on AI-CDSS experienced less vascular events of hemorrhagic stroke, myocardial infarction, or vascular death.


Poststroke Neurologic Deterioration Reduced With Tirofiban, Study Finds

Poststroke Neurologic Deterioration Reduced With Tirofiban, Study Finds

February 10th 2024

Tirofiban treatment in acute ischemic stroke reduced early neurological deterioration compared to oral antiplatelet therapy alone, warranting further investigation.


Increased Levels of Neurofilament Light and GFAP Confirmed During Acute Stroke

Increased Levels of Neurofilament Light and GFAP Confirmed During Acute Stroke

February 9th 2024

Elezanumab's biomarker analysis in stroke patients underscores its potential as a neuroprotective therapy for acute ischemic stroke management.


Fibrinogenase Injection Improves Functional Outcome Following Ischemic Stroke

Fibrinogenase Injection Improves Functional Outcome Following Ischemic Stroke

February 9th 2024

Over a 90-day period, investigators observed significantly lower functional outcomes on modified Rankin Scale and similar rates of bleeding and death when compared with control.


Santosh Murthy, MD, MPH

A National Registry Analysis on Minimally Invasive Surgery for Intracerebral Hemorrhage: Santosh Murthy, MD, MPH

February 8th 2024

The associate professor of neurology at Weill Cornell Medicine talked about a recent study that revealed that minimally invasive surgery significantly reduced the risk of mortality in patients with nontraumatic intracerebral hemorrhage. [WATCH TIME: 4 minutes]


Innovative Approaches and Treatment Inventions for Stroke Care at ISC 2024: Babak Navi, MD, MS

Innovative Approaches and Treatment Inventions for Stroke Care at ISC 2024: Babak Navi, MD, MS

February 7th 2024

The chief of the division of stroke and hospital neurology at Weill Cornell Medicine shared some of his thoughts on the promising clinical trials being presented at the 2024 International Stroke Conference. [WATCH TIME: 3 minutes]


Adrenomedullin Safe to Treat Ischemic Stroke, May Lead to Improved Outcomes

Adrenomedullin Safe to Treat Ischemic Stroke, May Lead to Improved Outcomes

February 7th 2024

In comparison with placebo, slightly better outcomes on modified Rankin Scale were observed with adrenomedullin.


Patricia C. Dugan, MD

Narrowing the Treatment Gap and Raising Awareness of Surgical Options for Epilepsy: Patricia C. Dugan, MD

February 6th 2024

The associate professor of neurology at NYU Grossman School of Medicine talked about the need for increased awareness in the medical community to address the underutilization of surgical interventions for refractory focal epilepsy. [WATCH TIME: 4 minutes]

© 2024 MJH Life Sciences

All rights reserved.